Both in Pharmaceuticals
Standard BioTools vs Greenwich LifeSciences
Over the past year LAB returned −50.7% and GLSI returned +88.8%; their daily moves had a correlation of 0.10.
LAB −50.7% GLSI +88.8%Growth of $1, one year, split-adjusted
| Metric | LAB | GLSI |
|---|---|---|
| Price | $0.6108 | $15.92 |
| Market cap | $241.1M | $233.7M |
| Today | +0.15% | −3.28% |
| 1 month | −19.9% | −5.9% |
| 6 months | −37.6% | −28.6% |
| Year to date | −52.3% | −24.2% |
| 1 year | −49.1% | +72.9% |
| Revenue growth (YoY) | −7.6% | — |
| Gross margin | 52.4% | — |
| Net margin | −133.1% | — |
| P/E (TTM) | 2.8× | — |
| Price / sales | 2.8× | — |
| Net cash | $476.4M | $8.9M |
| Dividend yield | — | — |
| Volatility (60d) | 45.5% | 91.9% |
| Short % of float | 1.1% | 24.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).